Pfizer announced in a press release highly encouraging results from their Phase 3 clinical trial. The Pfizer-BioNTech COVID-19 vaccine was 100% effective and generated a high antibody response in children aged 12–15.
Pfizer plans to submit these findings to the FDA and request emergency use authorization.
A Phase 3 study included 2,260 US participants. The research detected only 18 cases of Covid-19, and all were in the placebo group. None were in the study participants who received the vaccine.
Until recently, infection rates in children have been low. Children are often asymptomatic carriers but can pass the infection on to parents, teachers, and grandparents. The rise of variants such as B.1.1.7 is changing the way we view Covid-19 in children. A youth sports outbreak in Minneapolis was a wake-up call to public health experts.
February data from the American Academy of Pediatrics and the Children’s Hospital Association show over 3 million children have contracted Covid-19 resulting in 268 death. A disturbing breakdown of the CDC data shows that 75% of Covid-19 deaths among children of color.
The press release is available for review here.
This post was previously published on BeingWell.
You Might Also Like These From The Good Men Project
|Compliments Men Want to Hear More Often||Relationships Aren’t Easy, But They’re Worth It||The One Thing Men Want More Than Sex||..A Man’s Kiss Tells You Everything|
Join The Good Men Project as a Premium Member today.
All Premium Members get to view The Good Men Project with NO ADS.
A $50 annual membership gives you an all access pass. You can be a part of every call, group, class and community.
A $25 annual membership gives you access to one class, one Social Interest group and our online communities.
A $12 annual membership gives you access to our Friday calls with the publisher, our online community.
Register New Account
Need more info? A complete list of benefits is here.
Photo credit: iStock